A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry

被引:47
作者
Morrissey, B [1 ]
Downard, KM [1 ]
机构
[1] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia
关键词
antigenicity; influenza virus; mass spectrometery; protein interaction;
D O I
10.1002/pmic.200500642
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A proteomics-based approach is described that combines gel electrophoresis and MS in order to identify protein interactions and the nature of the interaction interface with high-sample throughput and sensitivity. Results for protein antigens of the influenza virus have demonstrated that the approach can be successfully employed to detect determinants within the hemagglutinin antigen of two divergent type A forms of the virus in present circulation. The determinants are localised to residues 206-224 following tryptic digestion of the hemagglutinin antigen. Specific peptide-antibody complexes formed after treatment of gel-recovered antigen are shown to be able to be preserved on the MALDI target array as has been previously demonstrated in this laboratory for whole virus. The approach has broad applicability for the analysis of a wide array of protein complexes with identification of the interaction interface in a single step with high-sample throughput and at low sample levels.
引用
收藏
页码:2034 / 2041
页数:8
相关论文
共 40 条
[1]   THE NEURAMINIDASE OF INFLUENZA-VIRUS [J].
AIR, GM ;
LAVER, WG .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1989, 6 (04) :341-356
[2]  
Alexander D. J., 1982, Veterinary Bulletin, V52, P341
[3]  
Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1
[4]  
[Anonymous], 2002, Wkly Epidemiol Rec, V77, P350
[5]  
[Anonymous], 1994, MORBIDITY MORTALITY
[6]  
Barry JohnM., 2004, THE GREAT INFLUENZA
[7]   STRUCTURE OF INFLUENZA-VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY [J].
BIZEBARD, T ;
GIGANT, B ;
RIGOLET, P ;
RASMUSSEN, B ;
DIAT, O ;
BOSECKE, P ;
WHARTON, SA ;
SKEHEL, JJ ;
KNOSSOW, M .
NATURE, 1995, 376 (6535) :92-94
[8]  
COLMAN PM, 1985, CURR TOP MICROBIOL, V114, P177
[9]  
DANIELS RS, 1985, B WORLD HEALTH ORGAN, V63, P273
[10]  
DEBI P, 2004, VIRUS RES, V106, P147